ILF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.978600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.945600E-01
Normal-vs-Stage2
9.290800E-01
Normal-vs-Stage3
5.348200E-01
Normal-vs-Stage4
6.610400E-01
Stage1-vs-Stage2
3.360200E-01
Stage1-vs-Stage3
8.834400E-01
Stage1-vs-Stage4
2.289600E-01
Stage2-vs-Stage3
3.333400E-01
Stage2-vs-Stage4
3.890600E-01
Stage3-vs-Stage4
3.513600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.230200E-01
Normal-vs-AfricanAmerican
3.519000E-01
Normal-vs-Asian
8.564800E-01
Caucasian-vs-AfricanAmerican
1.365980E-02
Caucasian-vs-Asian
3.942600E-01
AfricanAmerican-vs-Asian
2.656800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.252000E-01
Normal-vs-Female
9.861000E-01
Male-vs-Female
4.819800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.372600E-01
Normal-vs-Age(41-60Yrs)
8.504000E-01
Normal-vs-Age(61-80Yrs)
8.126400E-01
Normal-vs-Age(81-100Yrs)
6.676400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.024200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.476000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.266600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.346580E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.025200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.499200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.955400E-01
Normal-vs-Daily Drinker
1.859620E-01
Normal-vs-Weekly Drinker
7.936000E-01
Normal-vs-Occasional Drinker
5.686800E-01
Normal-vs-Social Drinker
5.704800E-01
Non Drinker-vs-Daily Drinker
6.407900E-02
Non Drinker-vs-Weekly Drinker
4.553400E-01
Non Drinker-vs-Occasional Drinker
2.573200E-01
Non Drinker-vs-Social Drinker
6.172200E-01
Daily Drinker-vs-Weekly Drinker
3.795800E-02
Daily Drinker-vs-Occasional Drinker
6.242900E-04
Daily Drinker-vs-Social Drinker
1.420620E-01
Weekly Drinker-vs-Occasional Drinker
8.775000E-01
Weekly Drinker-vs-Social Drinker
2.464600E-01
Occasional Drinker-vs-Social Drinker
5.046000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.822600E-01
Normal-vs-Grade 2
9.413600E-01
Normal-vs-Grade 3
9.607200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.750010E-01
Grade 1-vs-Grade 3
1.113390E-01
Grade 1-vs-Grade 4
8.822600E-01
Grade 2-vs-Grade 3
5.865000E-01
Grade 2-vs-Grade 4
9.413600E-01
Grade 3-vs-Grade 4
9.607200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.459200E-01
Normal-vs-NonDiabetic
9.428000E-01
Diabetic-vs-NonDiabetic
1.195150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.954600E-01
Normal-vs-NoPancreatitis
8.457200E-01
Pancreatitis-vs-NoPancreatitis
9.467600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.286200E-01
Normal-vs-N1
8.247600E-01
N0-vs-N1
1.203580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.341800E-01
Normal-vs-TP53-NonMutant
8.940800E-01
TP53-Mutant-vs-TP53-NonMutant
1.633680E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
